Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carmustine × 90 days × Clear all

Phase

Status

Active not recruiting 2 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Mantle-Cell 1

Interventions

pembrolizumab 64 Cyclophosphamide 38 Nivolumab 36 Cisplatin 34 Carboplatin 31 Paclitaxel 28 Radiotherapy 23 Gemcitabine 22 fludarabine 20 Ipilimumab 20 Dexamethasone 20 Surveys and Questionnaires 16 Standard of Care 16 Irinotecan 16 Doxorubicin 16 Docetaxel 16 Cetuximab 16 atezolizumab 15 Lenalidomide 15 Fluorouracil 15 Blood Specimen Collection 15 Trastuzumab 14 Prednisone 14 Oxaliplatin 14 regorafenib 13 Pemetrexed 13 lenvatinib 12 Rituximab 12 Etoposide 12 fludarabine phosphate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02896582 2026-01-14

LyMa101

The Lymphoma Academic Research Organisation

Phase 2 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡